Literature DB >> 32885374

Implementation of a Behavioral Economics Electronic Health Record (BE-EHR) Module to Reduce Overtreatment of Diabetes in Older Adults.

Hayley M Belli1, Sara K Chokshi2, Roshini Hegde3, Andrea B Troxel4, Saul Blecker2,5, Paul A Testa6,7, Judd Anderman6, Christina Wong6, Devin M Mann2,5,6.   

Abstract

BACKGROUND: Intensive glycemic control is of unclear benefit and carries increased risk for older adults with diabetes. The American Geriatrics Society's (AGS) Choosing Wisely (CW) guideline promotes less aggressive glycemic targets and reduction in pharmacologic therapy for older adults with type II diabetes. Meanwhile, behavioral economic (BE) approaches offer promise in influencing hard-to-change behavior, and previous studies have shown the benefits of using electronic health record (EHR) technology to encourage guideline adherence.
OBJECTIVE: This study aimed to develop and pilot test an intervention that leverages BE with EHR technology to promote appropriate diabetes management in older adults.
DESIGN: A pilot study within the New York University Langone Health (NYULH) EHR and Epic system to deliver BE-inspired nudges at five NYULH clinics at varying time points from July 12, 2018, through October 31, 2019. PARTICIPANTS: Clinicians across five practices in the NYULH system whose patients were older adults (age 76 and older) with type II diabetes.
INTERVENTIONS: A BE-EHR module comprising six nudges was developed through a series of design workshops, interviews, user-testing sessions, and clinic visits. BE principles utilized in the nudges include framing, social norming, accountable justification, defaults, affirmation, and gamification. MAIN MEASURES: Patient-level CW compliance. KEY
RESULTS: CW compliance increased 5.1% from a 16-week interval at baseline to a 16-week interval post intervention. From February 14 to June 5, 2018 (prior to the first nudge launch in Vanguard clinics), CW compliance for 1278 patients was mean (95% CI)-16.1% (14.1%, 18.1%). From July 3 to October 22, 2019 (after BE-EHR module launch at all five clinics), CW compliance for 680 patients was 21.2% (18.1%, 24.3%).
CONCLUSIONS: The BE-EHR module shows promise for promoting the AGS CW guideline and improving diabetes management in older adults. A randomized controlled trial will commence to test the effectiveness of the intervention across 66 NYULH clinics. NIH TRIAL REGISTRY NUMBER: NCT03409523.

Entities:  

Keywords:  behavioral economics; clinical decision support; diabetes; electronic health records

Mesh:

Year:  2020        PMID: 32885374      PMCID: PMC7661670          DOI: 10.1007/s11606-020-06119-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  34 in total

1.  Emotions and preventive health behavior: worry, regret, and influenza vaccination.

Authors:  Gretchen B Chapman; Elliot J Coups
Journal:  Health Psychol       Date:  2006-01       Impact factor: 4.267

Review 2.  Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings.

Authors:  Monique W M Jaspers; Marian Smeulers; Hester Vermeulen; Linda W Peute
Journal:  J Am Med Inform Assoc       Date:  2011-03-21       Impact factor: 4.497

Review 3.  Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis.

Authors:  Lorenzo Moja; Koren H Kwag; Theodore Lytras; Lorenzo Bertizzolo; Linn Brandt; Valentina Pecoraro; Giulio Rigon; Alberto Vaona; Francesca Ruggiero; Massimo Mangia; Alfonso Iorio; Ilkka Kunnamo; Stefanos Bonovas
Journal:  Am J Public Health       Date:  2014-10-16       Impact factor: 9.308

4.  Multiple chronic conditions and life expectancy: a life table analysis.

Authors:  Eva H DuGoff; Vladimir Canudas-Romo; Christine Buttorff; Bruce Leff; Gerard F Anderson
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

5.  Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

Authors:  Cynthia M Boyd; Jonathan Darer; Chad Boult; Linda P Fried; Lisa Boult; Albert W Wu
Journal:  JAMA       Date:  2005-08-10       Impact factor: 56.272

Review 6.  Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis.

Authors:  Humaira Hussein; Francesco Zaccardi; Kamlesh Khunti; Melanie J Davies; Emily Patsko; Nafeesa N Dhalwani; David E Kloecker; Ekaterini Ioannidou; Laura J Gray
Journal:  Diabetes Obes Metab       Date:  2020-03-18       Impact factor: 6.577

7.  Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial.

Authors:  Daniella Meeker; Jeffrey A Linder; Craig R Fox; Mark W Friedberg; Stephen D Persell; Noah J Goldstein; Tara K Knight; Joel W Hay; Jason N Doctor
Journal:  JAMA       Date:  2016-02-09       Impact factor: 56.272

Review 8.  American Geriatrics Society identifies another five things that healthcare providers and patients should question.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2014-02-27       Impact factor: 5.562

9.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

10.  American Geriatrics Society identifies five things that healthcare providers and patients should question.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2013-03-07       Impact factor: 5.562

View more
  7 in total

Review 1.  Applying Behavioral Economics Theories to Interventions for Persons with Diabetes.

Authors:  Susana R Patton; Christopher C Cushing; Amy Hughes Lansing
Journal:  Curr Diab Rep       Date:  2022-03-10       Impact factor: 4.810

2.  Design of Behavioral Economic Applications to Geriatrics Leveraging Electronic Health Records (BEAGLE): A pragmatic cluster randomized controlled trial.

Authors:  Tiffany Brown; Theresa A Rowe; Ji Young Lee; Lucia C Petito; Ryan Chmiel; Jody D Ciolino; Jason N Doctor; Craig R Fox; Noah J Goldstein; Darren Kaiser; Jeffrey A Linder; Daniella Meeker; Yaw Peprah; Stephen D Persell
Journal:  Contemp Clin Trials       Date:  2021-12-08       Impact factor: 2.226

3.  A Behavioral Economics-Electronic Health Record Module to Promote Appropriate Diabetes Management in Older Adults: Protocol for a Pragmatic Cluster Randomized Controlled Trial.

Authors:  Hayley M Belli; Andrea B Troxel; Saul B Blecker; Judd Anderman; Christina Wong; Tiffany R Martinez; Devin M Mann
Journal:  JMIR Res Protoc       Date:  2021-10-27

4.  Study on the Types of Elderly Intelligent Health Management Technology and the Influencing Factors of Its Adoption.

Authors:  Zhu Chen; Huiying Qi; Luman Wang
Journal:  Healthcare (Basel)       Date:  2021-11-02

5.  Effects of Behavioral Economics-Based Messaging on Appointment Scheduling Through Patient Portals and Appointment Completion: Observational Study.

Authors:  Su-Ying Liang; Cheryl D Stults; Veena G Jones; Qiwen Huang; Jeremy Sutton; Guy Tennyson; Albert S Chan
Journal:  JMIR Hum Factors       Date:  2022-03-30

6.  Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines.

Authors:  Arnold G Vulto; Isabelle Huys; Yannick Vandenplas; Steven Simoens; Florian Turk
Journal:  Appl Health Econ Health Policy       Date:  2022-08-16       Impact factor: 3.686

7.  A Qualitative Description of Clinician Free-Text Rationales Entered within Accountable Justification Interventions.

Authors:  Tiffany Brown; Brittany Zelch; Ji Young Lee; Jason N Doctor; Jeffrey A Linder; Mark D Sullivan; Noah J Goldstein; Theresa A Rowe; Daniella Meeker; Tara Knight; Mark W Friedberg; Stephen D Persell
Journal:  Appl Clin Inform       Date:  2022-09-07       Impact factor: 2.762

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.